INPP5D and Alzheimer disease: While data from our group agrees with the elevation of INPP5D mRNA levels in human AD post-mortem brains, we also found that aqueous-soluble SHIP1 protein levels are reduced in brain tissue from individuals diagnosed with AD compared with non-AD individuals [161].